The role of NK cells in the remarkable response of CT26 to CTLA4 blockade (Additional file 2: Figure S5) as well as the potential mechanism of NK activation through CD80 expressed on CT26 cancer cells remains to be elucidated by future experiments. The gene discussed is DDX53; the disease is cancer.